Picture of Abiomed logo

ABMD Abiomed Share Price

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

Momentum

Relative Strength (%)
1m-1.52%
3m+41.74%
6m+43.79%
1yr+40.74%
Volume Change (%)
10d/3m-0.76%
Price vs... (%)
52w High-1.1%
50d MA+18.67%
200d MA+31.39%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)70.71
PEG Ratio (f)9.08
EPS Growth (f)8.44%
Dividend Yield (f)n/a
Valuation (ttm)IndustryMarket
Price to Book Value11.06
Price to Tang. Book12.02
Price to Free Cashflow78.42
Price to Sales15.86
EV to EBITDA57.67

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital16.23%
Return on Equity18.24%
Operating Margin23.61%

Financial Summary

Year End 31st MarUnit201820192020202120222023E2024ECAGR / Avg
Total Revenue$m593.75769.43840.88847.521,031.751,135.191,313.7118.3%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%+149.64+92.65-19.61+9.43+4.81-6.96+15.87n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Mar 202331st Mar 2024
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2023 / 2024

Blurred out image of Abiomed EPS forecast chart

Profile Summary

ABIOMED, Inc. is a medical technology provider, which provides circulatory support and oxygenation. The Company develops, manufactures and markets its products, which are designed to enable the heart to rest by improving blood flow and/or performing the pumping of the heart. Its products are used in the cardiac catheterization lab or cath lab, by interventional cardiologists and in the heart surgery suite by cardiac surgeons for patients who are in need of hemodynamic support prophylactically or emergently before, during or after angioplasty, or heart surgery procedures. The Company's Impella device portfolio includes the Impella 2.5, Impella CP, Impella 5.0, Impella LD, Impella 5.5 and Impella RP devices. Its product pipeline includes Impella ECP, Impella XR Sheath, Impella BTR and precardiac. The Impella ECP device is designed for blood flow of greater than three and a half liters per minute. The Impella BTR device is designed to be a heart pump with integrated motors and sensors.

Directors

Last Annual
March 31st, 2022
Last Interim
September 30th, 2022
Incorporated
June 4th, 1987
Public Since
July 29th, 1987
No. of Shareholders
351
No. of Employees
2,003
Sector
Healthcare Equipment & Supplies
Industry
Healthcare
Exchange
us flag iconNASDAQ Global Select Market
Shares in Issue
45,091,184

ABMD Share Price Performance

Latest News for ABMD

Upcoming Events for ABMD

Q3 2023 ABIOMED Inc Earnings Release

Q4 2023 ABIOMED Inc Earnings Release

Similar to ABMD

Picture of 10X Genomics logo

10X Genomics

us flag iconNASDAQ Global Select Market

Picture of Accuray logo

Accuray

us flag iconNASDAQ Global Select Market

Picture of Acutus Medical logo

Acutus Medical

us flag iconNASDAQ Global Select Market

Picture of Akoya Biosciences logo

Akoya Biosciences

us flag iconNASDAQ Global Select Market

Picture of Align Technology logo

Align Technology

us flag iconNASDAQ Global Select Market

FAQ

Or unlock with your email

Or unlock with your email